PRESS RELEASE published on 01/19/2026 at 08:00, 9 months 22 days ago Oxurion annonce la suspension temporaire du programme de financement dédié à des investissements dans les actifs numériques et crypto-actifs Oxurion NV suspend temporairement son projet d'investissement dans les crypto-actifs en raison de la volatilité des marchés et des conditions actuelles, sans impact sur son modèle économique Investissement Suspension Crypto-actifs Volatilité Oxurion NV
PRESS RELEASE published on 01/19/2026 at 08:00, 9 months 22 days ago Oxurion kondigt de tijdelijke opschorting aan van het financieringsprogramma bestemd voor investeringen in digitale activa en crypto-activa Oxurion NV suspendiert Investitionsprojekt in digitale und Krypto-Assets aufgrund volatiler Märkte und geopolitischer Unsicherheiten, ohne Änderung des Kerngeschäftsmodells Oxurion NV Investitionsprojekt Digitale Assets Krypto-Assets Marktvolatilität
BRIEF published on 01/13/2026 at 18:05, 9 months 27 days ago Oxurion annonce une notification de transparence d'Atlas Special Opportunities II LLC Notification De Transparence Oxurion Opportunités Spéciales Atlas Sous-traitants Pharmaceutiques Seuil Des Actions
BRIEF published on 01/13/2026 at 18:05, 9 months 27 days ago Oxurion Announces Transparency Notification from Atlas Special Opportunities II LLC Transparency Notification Atlas Special Opportunities Oxurion Pharmaceutical Subcontractors Shares Threshold
BRIEF published on 01/13/2026 at 18:05, 9 months 27 days ago Oxurion reçoit une notification de transparence d'Atlas Special Opportunities II LLC Actions Transparence Atlas Special Opportunities Oxurion Investissements Numériques
BRIEF published on 01/13/2026 at 18:05, 9 months 27 days ago Oxurion receives a transparency notification from Atlas Special Opportunities II LLC Actions Transparency Atlas Special Opportunities Oxurion Digital Investments
PRESS RELEASE published on 01/13/2026 at 18:00, 9 months 27 days ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities II LLC Oxurion NV ontvangt transparantieverklaring van Atlas Special Opportunities II LLC waaruit blijkt dat drempel van 3% is onderschreden door verkoop van aandelen. Het bedrijf specialiseert zich in farmaceutische onderaannemers Oxurion NV Belgische Transparantiewetgeving Atlas Special Opportunities II LLC Farmaceutische Onderaannemers Transparantieverklaring
PRESS RELEASE published on 01/13/2026 at 18:00, 9 months 27 days ago Oxurion Receives Transparency Notification from Atlas Special Opportunities II LLC Oxurion NV receives transparency notification from Atlas Special Opportunities II, LLC regarding shareholding. Company specializes in acquiring stakes in European pharmaceutical subcontractors Transparency Notification Shareholding European Oxurion NV Pharmaceutical Subcontractors
BRIEF published on 12/17/2025 at 18:05, 10 months 23 days ago Oxurion Announces Transparency Notification from Atlas Special Opportunities Shares Transparency Atlas Belgium Oxurion
BRIEF published on 12/17/2025 at 18:05, 10 months 23 days ago Oxurion annonce une notification de transparence d'Atlas Special Opportunities Actions Atlas Transparence Belgique Oxurion
Published on 11/10/2026 at 11:46, 5 minutes ago Apex Extends Trinity Zone in West Step-out Drilling With 2.52% REO Over 223.3 m and 2.49% REO Over 123.3 m at Rift
Published on 11/10/2026 at 11:00, 51 minutes ago 3D Induced Polarization Survey Identifies a Large Drill Target at East Goldfield
Published on 11/10/2026 at 08:00, 3 hours 51 minutes ago PEL 82 - QatarEnergy to Acquire 25% Participating Interest from Chevron
Published on 11/10/2026 at 02:45, 9 hours 6 minutes ago Presentation to Zurich Precious Metals Summit
Published on 11/09/2026 at 23:10, 12 hours 41 minutes ago Ur-Energy Reports Third Quarter 2026 Results
Published on 11/10/2026 at 11:16, 35 minutes ago Second drill rig mobilised as Lionheart construction ramps up
Published on 11/10/2026 at 11:04, 47 minutes ago aap increases revenue by 2% in the third quarter of 2026 – on top of the already high prior-year level
Published on 11/10/2026 at 10:50, 1 hour 1 minute ago German R&D Tax Credits: New Administrative Instruction by Federal Ministry of Finance Tightens Documentation Requirements
Published on 11/10/2026 at 10:09, 1 hour 42 minutes ago EQS-Adhoc: Emerald Horizon AG plans to raise approximately EUR 135 million in equity by 2028 and resolves first cash capital increase
Published on 11/10/2026 at 11:02, 49 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 11:02, 49 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of October 31, 2026
Published on 11/10/2026 at 07:00, 4 hours 51 minutes ago bioMérieux receives U.S. FDA 510(k) Clearance and IVDR CE marking for VITEK® PRO, its new automated ID/AST instrument to support the fight against antimicrobial resistance
Published on 11/10/2026 at 07:00, 4 hours 51 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine et le marquage CE selon l’IVDR pour VITEK® PRO, son nouvel instrument automatisé d’identification et d’antibiogramme contribuant à la lutte contre l’antibiorésistance
Published on 11/09/2026 at 18:30, 17 hours 21 minutes ago Air Liquide has successfully issued a CHF 390 million multi-tranche bond